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Study of intestinal absorption of calcium in patients with renal
failure. Absorption of 47Ca was measured with a method which
assesses true absorption and shows good reproducibility in
256 subjects, including 47 normal, 16 with early renal failure
(serum creatinines  2.5 mg/100 ml), 96 with advanced renal
failure (serum creatinines >2.5 mg/tOO ml), 58 undergoing
regular hemodialysis, and 39 renal transplant recipients. In
normal subjects 47Ca absorption varied inversely with previous
habitual dietary calcium intake, and absorption did not differ
from normal in patients with early renal failure. In patients with
advanced renal failure and in those treated with hemodialysis,
47Ca absorption was below normal; deviation below normal was
greater when dietary calcium intake was considered. In individual
patients, calcium absorption often increased slightly with initiation
of regular hemodialysis, but values generally remained sub-
normal. Renal transplantation restored absorption to normal,
but absorption was reduced in those with serum creatinine
>2.0 mg/100 ml and was inversely related to prcdnisone dosage.
Thus true intestinal calcium absorption is clearly impaired with
renal failure although the defect cannot be detected with mild
renal failure. The diets of these patients contain tow quantities
of calcium, probably contributing to hypocalcemia in uremic
patients. The impaired calcium absorption is discussed in relation
to the kidney's role in producing I ,25-dihydroxycholecalciferol,
the presumed active form of vitamin D.
Etude de l'absorption intestinale de calcium chez des malades
atteints d'insuffisance rénale. L'absorption de 47Ca a été mesurée
par une méthode qui determine l'absorption vraie et posséde une
bonnc reproductibilité chez 256 sujets, dont 47 sujets normaux,
16 au stade initial de l'insuffisance rénale (créatinines plasma-
tiques <2.5 mg/tOO ml), 96 atteints d'insuffisance rénale sévére
(créatinines plasmatiques >2.5 mg/100 ml), 58 soumis a l'hémo-
dialyse périodique et 39 transplantés. Chez les normaux l'ab-
sorption de 47Ca vane en fonction inverse des habitudes alimen-
taires antéricures, elle n'est pas différente de celle des sujets au
stade initial de l'insuffisance rénale. Chez les malades atteints
d'insuffisance rénale avancée et ceux traités par hémodialyse
l'absorption de 47Ca était inférieure a Ia normale et l'écart
était plus grand quand l'ingestion de calcium était prise en
consideration. Chez certains malades une augmentation modérée
de l'absorption contemporaine du debut de l'hémodialyse
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périodique a été observée, mais dans l'ensemble les valeurs sont
demeurées subnormales. La transplantation a ramcné l'absorp-
tion a la normale sauf chez les malades dont Ia crdatinine était
supérieure a 2.0 mg/100 ml ct l'absorption était invcrsement
corrélée a la posologie de la Prednisone. Ainsi l'absorption in-
testinale vraie de calcium est nettement diminuée par l'insuff i-
sance rénale quoiquc le deficit ne puisse être détecté au cours de
l'insuffisancc rénale modérée. La ration alimentaire de ces
maladcs conticnt pcu de calcium, ce qui contribue probablement
a l'hypocalcémie des malades urémiques. Le deficit d'absorption
de calcium est discuté en tenant compte du role du rein dans Ia
production du I ,25-dihydroxycholecalciférol, Ia forme active
présumée de Ia vitamine D.
In patients with chronic renal failure, impaired intestinal
absorption of radiocalcium has been reported by a number
of investigators [1—7]. However, considerable overlap be-
tween values obtained in uremic patients and those in
normal subjects has been found with use of isotopic me-
thods which measure the actual calcium absorption [2, 3, 7].
Such variability could be related to variations in the degree
of impairment of renal function in the populations studied
or to differences in the levels of previous habitual dietary
intake of calcium, a factor which clearly affects the ab-
sorption of calcium in man [8—11]. In one study, the re-
lation between calcium absorption to the previous dietary
calcium intake was given for only 11 uremic patients [7].
It is not known when in the course of progressive renal
failure the abnormality of calcium absorption first becomes
apparent. Also, reports dealing with the effect of improving
the uremic state on intestinal absorption of calcium are
conflicting. Genuth, Vertes and Leonards [4] found no
improvement of calcium absorption following initiation of
therapy with regular hemodialysis, while Messner et al [5]
and Reeker and Saville [7] reported slight improvement
toward normal after initiation of therapy with regular
hemodialysis. The influence of renal transplantation on in-
testinal absorption of calcium has not been systematically
evaluated.
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Table 1. Clinical and biochemical data and results of intestinal absorption of calcium
Observation Normal
Chronic renal failure Patients
treated
with regular
hemodialysis
Renal transplant recipients
Total
Group
SCr 2.0 mg/ Sr> 2.0 mg/
100 ml 100 ml
Mild-
Moderate
S1a2.5mg/
Advanced
Scr> 2.5 mgI
lOOm!
Total
Group
100 ml
Patients, total no. 47 16 96 112 58 39 28 11
(male/female) (29/18) (14/2) (89/7) (103/9) (48/10) (36/3) (26/2) (10/1)
Age, years 37± lOb 46± 13 46± 10 46± 11 40.0± 11 36±9 37±9 32±8
Range (20—57) (19—75) (19—65) (19—75) (19—64) (21—52) (21—52) (21—43)
Fraction of 47Ca 0.25±0.06 0.25±0.05 0.17±0.06 0.18±0.07 0.19±0.05 0.21±0.07 0.22±0.08 0.18±0.07
absorbed (0.14—0.35) (0.18—0.36) (0.07—0.40) (0.07—0.40) (0.11—0.41) (0.08—0.38) (0.09—0.38) (0.08—0.30)
Dietary calcium 795± 350 475±270 300±240 325±250 500±235 1125±740 1170± 770 1015±690
intake, mg/day (400—1600) (170—1150) (130—1150) (130—1150) (200—1250) (175—3250) (175—3250) (390—2800)
mg/lOU ml 1.1±0.2 1.7±0.5 12.7±7.0 11.1±7.6 10.5±3.4 1.8±0.8 1.4±0.3 2.8±0.7
S, mg/lOU ml 3.4±0.6 2.9±0.6 6.6±2.4 6.0±2.6 6.0± 1.7 2.8±0.8 2.8±0.6 2.8± 1.3
Sca, mg/lOOm! 9.8±0.5 9.2±0.7 8.6± 1.3 8.7± 1.2 9.3± 1.0 9.8±0.8 9.9±0.8 9.5±0.5
SMg, mg/lOOml 2.6±0.2 2.5±0.3 3.0±0.7 2.9±0.7 3.5± 1.2 2.5±0.3 2.5±0.3 2.7±0.4
Duration of — — — 13.1 11.4 12.1 11.7 11.3 11.0 14.1 13.6
treatment, mos (1—44) (1—41) (1—38) (1-41)
Dose of prednisone, — — — — — 27± 14.2 27± 15.9 28± 10.2
mg/day (5—70) (5—70) (12.5—45)
a Sr= serumcreatinine; S= serum phosphorus; SCa=serum calcium; SMg= serum magnesium.
b Data are expressed as mean SD; numbers in parentheses represent the range.
In the present study, 300 determinations of fractional
absorption of calcium were carried out utilizing 47Ca in
256 subjects, including 47 normal subjects, 16 patients with
early and 96 with advanced renal failure, 58 patients being
treated with regular hemodialysis, and 39 renal transplant
recipients. The effect of therapy with vitamin D3 (chole-
calciferol) was also evaluated. Calcium absorption was
determined utilizing a method [12] which takes into account
the poo1 size and turnover of radiocalcium and permits the
estimation of true absorption. The results were interpreted
in relation to the previous habitual dietary intake of calcium.
Methods
The normal subjects were ambulatory hospital and la-
boratory employees who were free of known diseases
affecting calcium metabolism. The patients were taken from
the outpatient or inpatient population of our hospitals.
The ages and sex distribution of the subjects are shown in
Table 1. All patients had an established diagnosis of primary
renal disease. They included those with mild-to-moderate
renal failure (serum creatinine  2.5 mg/100 ml), patients
with advanced renal failure (serum creatinine >2.5 mg/
100 ml), patients treated with regular hemodialysis, and
renal transplant recipients. The patients treated with hemo-
dialysis were studied from 1 to 44 months after initiation of
treatment. The dialyses were carried out 2 to 3 times/week
in the inpatient units or in the patient's home, utilizing a
coil-type dialyzer for 6 to 9 hr on each occasion, or a Kiil
dialyzer for 10 to 12 hr. The concentration of calcium in
dialysate was 6 mg/100 ml in most patients, although six
patients were treated with dialysate containing 8 mg of
calcium/l00 ml for 12 to 18 months before the study of
absorption [13]. Aluminum hydroxide gel was prescribed
for the patients treated with hemodialysis, but the degree
of adherence to this therapy was variable. All patients
received one multivitamin capsule containing 400 I. U. of
vitamin D2 each day.
The renal transplant recipients were studied 1 to 41
months after surgery, when dietary intake and immuno-
suppressive therapy were relatively constant. The details of
the management of these patients have been described else-
where [14].
Intestinal absorption of calcium was measured in the
first 62 studies in a manner identical to that described by
Curtis, Fellows and Rich t121 using a large volume scintilla-
tion counter (Armac, Packard Instrument Co.). Between
9 and 10 a. m. on the first day, a control measurement of
arm radioactivity was made. Each individual then received
intravenously a measured dose of 47Ca (') 0.90 to 1.10
liCi, with 0.1 mg of CaC12 in I ml of saline. The subjects
fasted after midnight, and on the second day, 23 hours after
the intravenous dose, the radioactivity in the arm was
measured (A1); then they received by mouth 25 ml of a
solution containing 20 jiCi of 47Ca (1) and 200 mg of
stable calcium as calcium gluconate. The container was
rinsed twice with 20 ml of distilled water which the subject
also swallowed. Two hours later, they ate their usual
breakfast. At 25 and 49 hr after the oral dose, on days 3
and 4, radioactivity in the forearm was again measured,
A2 and A3, respectively. For measurement of the forearm
radioactivity, the subject was seated in a special chair care-
fully positioned on one side of the counting chamber with
his body shielded from the detector. The forearm was insert-
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ed into the chamber, with its position standardized by
having the individual firmly grasp a bar located deep within
the counting chamber. Measurement of body-background
was made with the subject seated in exactly the same position
with the arm withdrawn from the chamber. Forearm and
background radioactivity was measured over 3 to 5 mm,
providing total counts sufficient to give an error of less than
2%. The radioactivity from 47Ca was separated from that
of the daughter isotope, 47Sc, by adjusting the spectro-
photometer to measure only emissions above 1.0mev.
Calculations were made assuming that the distribution of
the absorbed isotope within the arm after 23 hr is
similar to the distribution of the intravenously administered
dose. Thus, the forearm radioactivity measured 25 hr after
the oral dose (A2) represents the fraction absorbed (cc)
multiplied by the fraction of the intravenous dose present
in the forearm (A1/[). However, residual counts remain
from the intravenous dose; this activity decays according to
the biologic turnover (/3), which can be assessed from the
change in radioactivity from day 3 to day 4 (A3/A2).
Thus, A2=cc l0(A1/10)+A1 or,
cc = (A2/A i — A3/A2)(t/I,)
The results of the first 62 studies revealed the mean value
of /3 to be 0.92, which is almost identical to that reported by
Curtis et al [11]. Since a change in value of /3 of 15% affects
cc by only 1 to 3%, /1 can be assumed to be 0.92, and it is
not necessary to count radioactivity in the arm on the third
day, and the formula becomes:
cc' =(A2/A1 —0.92) (1/1)
To test the validity of this assumption, calculated values of
cc' are compared with cc in the 62 patients (Fig. 1); the results
from the two calculations are nearly identical; therefore,
the latter method of calculation of cc as a measure of
absorption was employed for all the present data,
To further validate the arm-counting method, intestinal
absorption of calcium was simultaneously determined in
ten subjects by measuring fecal recovery of 47Ca after its
oral administration. Subjects received by mouth 1.5 g of
BaSO4, as a nonabsorbable fecal marker on the day before
ingestion of the 47Ca. Stools were collected and pooled for
5 to 6 days, and then the feces were collected separately on
each day; when the radioactivity in the daily specimens fell
below 1 % of the ingested dose, stool collections were
discontinued. Total fecal radioactivity and the quantity of
BaSO4 were determined [15]. Only determinations with
recovery of BaSO4 within 5% of the administered dose were
considered valid. Absorption of 47Ca was calculated from
the formula:
radioactivity recovered in fecesAbsorption 1 — total administered radioactivity
The values of calcium absorption determined simultaneous-
ly by forearm counting and by fecal recovery fell near the
line of identity (Fig. 2); these results are similar to those
reported by Curtis et al [121 and Wills et al [16].
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Fig. 1. A comparison of calcium absorption utilizing the abbre-
viated method (cc') and the more complete protocol (cc). Each
point represents the observations in a separate individual.
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Fig. 2. A comparison of the fraction of 47Ca absorbed measured
by the arm-counting method with simultaneously measured 47Ca
absorption determined from the fecal recovery method. Each point
represents a different patient. The patients represented by closed
symbols (.) are from the present study; those by the open sym-
bols (0) were studied by Curtis et al [11], and those by the x 's,
by Wills et al [161. The data from one patient from the latter
group, with fractional absorption rates of 0.84 and 0.82 by the
two methods, were omitted from this illustration.
The total quantity of 47Ca necessary for the performance
of the test was substantially reduced by first giving an oral
dose of 7 to 8 jsCi of 47Ca, followed by an intravenous dose
of 1.5 to 2.0 jsc 5 to 14 days later. Forearm radioactivity
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was measured 23 to 25 hours after administration of both
the oral and intravenous doses of 47Ca, and c' was cal-
culated using the principles described above in a manner
described by Wills et al [16]. The lower quantity of radio-
isotope made the test more economical and permitted per-
formance of the test at more frequent intervals on the same
patient.
In ten normal subjects, 16 patients with renal failure, and
4 with other disorders, the absorption of 47Ca was measured
on two occasions, separated by periods ranging between
one and 25 months. The results demonstrated good re-
producibility in the same subject (Fig. 3).
In 15 normal and nine uremic patients undergoing therapy
with hemodialysis, the intestinal absorption of calcium was
measured before and seven days after the daily oral ad-
ministration of 1 mg (40,000 I. U.) of vitamin D3.
The previous habitual dietary intake of calcium was
estimated from a detailed interview performed by the same
dietitian in a manner described elsewhere [17]. Serum con-
centrations of creatinine, phosphorus, calcium and magne-
sium were measured by methods previously reported [18].
The following parameters were considered in the sta-
tistical evaluation of the data: fractional absorption of
calcium (a'), dietary intake of calcium, serum levels of
creatinine, calcium, phosphorus, and magnesium and the
age of the subject. The duration after initiation of herno-
dialysis or a renal transplantation as well as the daily dosage
of prednisone therapy in the transplant recipients were also
considered. Possible associations were assessed by the corre-
lation coefficients between the various factors utilizing
standard statistical methods [19].
0.2 0.3
Initial measurement
Results
A summary of results, showing the characteristics of all
subjects, including age, sex, dietary calcium intake, frac-
tional absorption of calcium and plasma biochemical find-
ings, is given in Table 1. There was a significant inverse
relation between the fractional absorption of the test dose of
47Ca in the normal subjects and the previous habitual
dietary calcium intake (Fig. 4), but the fractional absorption
was not related to the age or sex of the subjects.
In patients with mild or moderate renal failure, the mean
absorption of 47Ca was not different from that of normal,
and most values were in the normal range when evaluated
in relation to the previous calcium intake (Fig. 5). In
patients with advanced renal failure, the fractional ab-
sorption of calcium was significantly below normal; the
dietary intake of calcium was generally low in this group
with a mean value well below normal. The difference be-
tween the calcium absorption observed in this group and
normal subjects is amplified when the previous dietary intake
of calcium is taken into consideration, with only 41 of 96
patients within the normal range (Fig. 6). For the total
group of patients with renal failure, there was an inverse
correlation between calcium absorption and the levels of
serum creatinine, r =
—0.22, P <0.05. in the uremic pa-
tients, calcium absorption was unrelated to either serum
calcium level or the previous dietary intake of calcium.
The mean fractional absorption of calcium in patients
treated with hemodialysis was not different from that ob-
served in patients with advanced renal failure although the
dietary intake of calcium was higher in the former. When
dietary calcium intake is taken into consideration, 37 of
the 58 patients had values in the normal range (Fig. 7). In
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Fig. 3. A comparison of the fraction of 47Ca absorbed when the
same subject was studied on two separate occasions, the two
studies separated by 1 to 25 months; the previous dietary intake
of calcium did not differ significantly in each individual patient.
0.5 1.0 1.5
Calcium intake, g/day
Fig. 4. The relationship between the fraction of 47Ca absorbed and
the previous habitual dietary intake of calcium in normal subjects.
Each point represents a separate individual; males (.), females
(a); the interrupted lines encompass the 95% confidence limits
for individual values.
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Fig. 5. The fraction of 47Ca absorbed in patients with mild-to- Fig. 7. The fraction of 47Ca absorbed in uremic patients under-
moderate renal failure (serum creatinine  2.5 mg/100 ml) in going treatment with regular hemodialysis in relation to their
relation to the previous dietary intake of calcium. The symbols previous dietary intake of calcium. Symbols are as in Fig. 4.
are similar to those in Fig. 4. The normal range is superimposed.
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Fig 6. The fraction of 47Ca absorbed in patients with advanced
rena/failure (serum creatinine >2.5 mg/100 ml) in relation to the
previous dietary intake of calcium. Symbols are similar to those
in Fig.4.
eight of 11 patients, there was a small but definite increase
toward normal when 47Ca absorption was measured before
and after initiation of hemodialysis (Fig. 8).
In the renal transplant recipients, fractional absorption
was in the normal range in most of the patients (Fig. 9).
In four patients the absorption was higher than normal;
one of them had persistent hypercalcemia and other evidence
of secondary hyperparathyroidism. There was a significant
inverse relationship between the fractional absorption of
47Ca and the daily dosage of prednisone, r= —0.36, P= 0.02.
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Moreover, when the renal transplant recipients were divided
into those with serum creatinine  2.0 and those with serum
creatinine > 2.0 mg/l00 ml, the mean calcium absorption
in the latter was lower than those in normal subjects and in
transplant recipients with serum creatinine  2.0 mg/I 00
ml, despite similar doses of prednisone and levels of dietary
calcium intake. In ten of 15 patients who were studied both
before and 1 to 12 months after renal transplantation, the
absorption of calcium either improved or remained within
the normal range.
There was a small but significant increase in the frac-
tional absorption of 47Ca following treatment with chole-
calciferol in both normal subjects and in patients treated
with hemodialysis. In these normal subjects, fractional
absorption increased from 0.25 0.012 (sa) to 0.28 0.016
and in the uremic patients, from 0.17±0.015 to 0.19±
0.0 12. Utilizing the paired t test, the changes in both groups
were statistically significant, but the increments in the two
groups did not differ from each other.
Discussion
In the intestine, part of ingested calcium is absorbed,
i. e., transported from the lumen into the blood, while at
the same time an amount of calcium passes from the blood
into the gut, the so-called endogenous fecal calcium [20,
211; net absorption of calcium represents the difference
between these two parameters. When radiocalcium is given
by mouth, the fraction absorbed from the intestine is
diluted in a large miscible pool of stable calcium, causing
the specific activity to be very low in blood; therefore the
fraction of the absorbed radiocalcium which returns to the
gut via endogenous secretion is quite small. Failure to
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Fig. 8. Fraction of 47Ca absorbed in 11 uremic patients who were
studied before and after initiation of therapy with regular hemo-
dialysis. The open symbols (0) indicate values obtained before
therapy was initiated while the closed circles indicate those after
treatment was begun. The lines connect values obtained in the
same patient. The shaded area is the normal range.
correct the measured absorption for such losses resulted in
an average error of only 3% [221. The combined use of
intravenous and oral doses of 41Ca circumvents differences
due to variations in the size of the miscible pooi of calcium,
since the distribution of the absorbed fraction of the oral
dose of the isotope is similar to the distribution of the
intravenous dose, with identical fractions appearing in the
arm [12]. Moreover, the similarity between the values of
intestinal absorption obtained when the same individual
was tested on more than one occasion indicates that this
method yields reproducible results; these observations are
similar to previous reports demonstrating little variability
in intestinal absorption of calcium on repeated testing in
the same individual [22, 23].
The present results of the fractional absorption of calcium
in normal subjects agree quantitatively with the mean
absorption of 22 8.1 % in normal individuals reported by
Recker and Saville, who measured absorption using a
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Fig. 9. Fraction of 47Ca absorbed in renal transplant recipients
in relation to their previous dietary intake of calcium. The sym-
bols are as in Fig. 4.
double isotope method and employed a similar quantity of
stable calcium as a carrier [7]. The values of fractional
absorption found in our normal subjects are lower than
those reported by others who gave radiocalcium with food
[11] or with a smaller quantity of stable calcium as carrier
[2, 3].
Our data confirm previous observations [8—111 showing
an inverse relation between the fraction of radiocalcium
absorbed and the previous habitual dietary intake of cal-
cium in normal subjects. Among our normal group, the
fractional absorption of calcium did not vary with age;
this observation differs from previous reports which include
more subjects in younger or older age groups and show an
inverse relation between calcium absorption and age
[24, 25]. The narrower age range of our subjects may ac-
count for this discrepancy.
The results of the present study clearly indicate that
intestinal absorption of calcium in patients with mild to
moderate renal failure is not different from normal but it is
impaired in patients with advanced uremia. Several in-
vestigators have reported reduced mean values of calcium
absorption in patients with renal failure with the use of
various methods which estimate true absorption of calcium
f2, 3, 7]; however, considerable overlap exists between
results found in normal subjects and uremic patients. Ogg
found values within his normal range in 16 of 23 azotemic
patients [31 and Recker and Saville reported results in the
lower part of the normal range in most uremic patients [7].
The overlap between uremic patients and normal subjects
could be related to variations in the degree of renal in-
sufficiency, failure to relate calcium absorption to the
previous dietary intake of calcium, and the occurrence of
the same wide variation in absorption from one azotemic
patient to another, as exists in normal subjects. The corre-
lation between calcium absorption and the serum creatinine
level suggests that absorption may be worse as renal func-
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tion decreases. Reeker and Saville also noted such a re-
lationship in azotemic patients with blood urea nitrogen
(BUN) concentrations under 150 mg/l00 ml, although they
found radiocalcium absorption to be increased above
normal in two of five patients with BUN levels exceeding
lSOmgflOOml. The levels of BUN were not routinely
measured in the present patients, and most patients in the
present population either received protein restricted diets
or treatment with hemodialysis before azotemia of this
degree developed. Also, the intestinal absorption of calcium
involves several distinct processes, including active trans-
port against a chemical gradient and passive diffusion down
a chemical gradient, which may or may not be facilitated
[261. it is possible that uremia or kidney disease may impair
only a single component of the transport process, and there
could be different degrees of compensatory increases in the
unaffected mechanisms resulting in variability in total ab-
sorption from one patient to another. The present study
does not permit differentiation between these possibilities.
The present observations in patients treated with hemo-
dialysis are similar to previous reports of others who found
little [5, 7] or no improvement [4] in calcium absorption in
uremic patients treated with hemodialysis. However, a
larger fraction of our patients had results within the low
normal range when the results are evaluated in relation to
previous dietary intake, suggesting that there may be partial
reversal of the defect of intestinal calcium absorption after
regular hemodialysis. Among both patients with chronic
renal failure and those treated with hemodialysis, there was
no relationship between the fraction of radiocalcium ab-
sorbed and the previous dietary intake of calcium. The
distribution of dietary calcium intake in these patients was
skewed toward the low range, which could account for this
lack of relationship. Alternatively, it is plausible that renal
failure may impair mechanisms by which the organism
modifies absorption of calcium in response to changes in
dietary intake of this ion. Indeed, there is some support for
the latter possibility from data derived from metabolic
studies in patients with renal failure. Uremic patients are
usually in negative balance for calcium, with fecal losses
equal to or greater than dietary intake when they ingest
their usual low calcium diet [27—29]; with ingestion of
larger quantities of calcium, fecal losses do not increase
proportionately and they remain in positive balance for
this ion [30—32].
The diets ingested by uremic patients in the present
population contained very low quantities of calcium; this
was not due to selection of one specific group of patients,
since these patients were managed by many different physi-
cians in the Los Angeles area. This reduced dietary intake
of calcium is probably related to the ingestion of protein-
restricted diets by these patients. The intake of diets con-
taining a limited amount of calcium and defective intestinal
calcium absorption probably both contribute significantly
and compound each other in leading to deranged calcium
homeostasis in patients with chronic renal failure.
In the patients with mild renal failure, the mean level of
serum calcium was significantly lower than normal (Table 1).
This mild hypocalcemia occurred despite a mean frac-
tional absorption of calcium which was not different from
normal and a mean level of serum phosphorus which was
significantly lower than that of normal. These observations
suggest that factors other than hyperphosphatemia [33] or
defective intestinal calcium absorption may underlie the
mild hypocalcemia observed in these patients with mild-to-
moderate renal failure.
The observation that intestinal absorption of calcium,
viewed in relation to previous dietary intake of calcium, is
within the normal range in most renal transplant recipients
indicates that the defect in calcium absorption is reversed
when renal function is restored to normal; however, in-
testinal absorption of calcium remains abnormal if renal
function is not adequately improved after renal transplan-
tation. Short term treatment with glucocorticoids impairs
calcium absorption [20, 34, 35], and our observations in
renal transplant recipients suggest that such an effect from
prednisone may be dose-related during its long-term ad-
ministration.
The mechanisms underlying impaired calcium absorption
in chronic renal failure remain obscure [36]. Metabolic
studies showing that large pharmacological doses of vitamin
D can overcome defective absorption of calcium in chronic
renal failure led to the postulate that uremia causes a
vitamin D-resistant state [27—29]. It has been shown that
I ,25-dihydroxycholecalciferol (1 ,25-(OH)2-CC), the most
active known form of the vitamin [37, 38] is produced only
in the kidney (39), raising the possibility that decreased
production of 1,25-(OH)2-CC by the diseased kidney could
lead to impaired calcium absorption and the apparent
vitamin D-resistance found in uremia. In support of this
possibility, observations in our laboratory indicate that
1,25-(OH)2-CC may be more than 400 times more potent
than cholecalciferol in stimulating calcium absorption and
elevating serum calcium in uremic patients [40]. Our failure
to restore calcium absorption to normal following the
improvement of uremia by hemodialysis is also consistent
with this view. On the other hand, calcium absorption was,
slightly improved following treatment with hemodialysis,
findings consistent with those in experimental animals which
suggest that uremia, per se, contributes to reduced intestinal
absorption of calcium [36, 41—43].
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